Skip to content

10x Genomics, Inc. TXG Income Statement

TTM Q1 '26TTM Q4 '25TTM Q3 '25TTM Q2 '25TTM Q1 '25
$638.78M+2.3%$642.82M+5.2%$641.81M+1.9%$644.47M+2.0%$624.66M-0.1%
$194.17M-1.8%$198.94M+1.3%$200.02M-4.9%$196.59M-12.0%$197.65M-10.8%
$444.61M+4.1%$443.88M+7.1%$441.79M+5.4%$447.88M+9.7%$427.01M+5.7%
69.6%+1.2pp69.1%+1.2pp68.8%+2.3pp69.5%+4.8pp68.4%+3.8pp
$231.23M-11.2%$238.63M-9.8%$249.63M-5.1%$258.61M-1.8%$260.31M-4.3%
$292.78M-15.9%$316.13M-8.2%$333.34M-1.0%$339.69M+0.7%$348.3M+0.7%
$483.32M-19.4%$504.87M-17.1%$533.07M-13.9%$548.4M-17.1%$599.4M-11.7%
-$38.7M+77.5%-$60.99M+68.7%-$91.28M+54.3%-$100.53M+60.3%-$172.39M+37.3%
-6.1%+21.5pp-9.5%+22.4pp-14.2%+17.5pp-15.6%+24.5pp-27.6%+16.3pp
$19.46M+2.5%$21.08M+25.0%$18.19M-24.2%$21.2M+6.0%$18.99M+5.9%
-$19.25M+87.5%-$39.91M+77.5%-$73.09M+58.4%-$79.33M+66.0%-$153.4M+40.3%
$3.41M-6.2%$3.64M-26.2%$3.23M-51.4%$5.27M-19.6%$3.63M-50.8%
-$22.66M+85.6%-$43.54M+76.2%-$76.32M+58.2%-$84.6M+64.7%-$157.04M+40.6%
-3.5%+21.6pp-6.8%+23.1pp-11.9%+17.1pp-13.1%+24.8pp-25.1%+17.1pp
-$0.17+87.0%-$0.35+77.1%-$0.63+58.8%-$0.71+64.9%-$1.31+41.3%
-$569K+99.6%-$24.79M+84.4%-$56.4M+65.4%-$66.98M+69.0%-$137.68M+41.8%
-0.1%+22.0pp-3.9%+22.1pp-8.8%+17.1pp-10.4%+23.8pp-22%+15.8pp
-$38.7M+77.5%-$60.99M+68.7%-$91.28M+54.3%-$100.53M+60.3%-$172.39M+37.3%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

What are 10x Genomics, Inc.'s profit margins?
Gross margin is 69.6% and operating margin is -6.1%, with a -3.5% net margin.
Where does 10x Genomics, Inc.'s income statement data come from?
Every line is extracted from 10x Genomics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.